Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...
Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, ...
Postoperatively, the patient encountered multiple complications, including recurrence of BI, FTT, constipation, dysautonomia, visceral hyperalgesia and neurogenic bladder, necessitating specific ...